Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis.
Fischer L; Jiang L; Bittenbring JT; Huebel K; Schmidt C; Duell J; Metzner B; Krauter J; Glass B; Huettmann A; Schaefer-Eckart K; Silkenstedt E; Klapper W; Hiddemann W; Unterhalt M; Dreyling M; Hoster E; German Lymphoma Alliance (GLA) and the German Low-Grade Lymphoma Study Group (GLSG).
Ann Hematol
(Unknown)
Published: 2023
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation …
Stadler M; Hambach L; Dammann E; Diedrich H; Kamal H; Hamwi I; Schultze-Florey C; Varvenne M; Ehrlich S; Buchholz S; Koenecke C; Beutel G; Weissinger EM; Krauter J; Eder M; Hertenstein B; Ganser A.
Ann Hematol
(Unknown)
Published: 2023
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherap…
Araie H; Arai Y; Kida M; Aoki J; Uchida N; Doki N; Fukuda T; Tanaka M; Ozawa Y; Sawa M; Katayama Y; Matsuo Y; Onizuka M; Kanda Y; Kawakita T; Kanda J; Atsuta Y; Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy.
Ann Hematol
(Unknown)
Published: 2023
Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study…
Viprakasit V; Hamdy MM; Hassab HMA; Sherief LM; Al-Bagshi M; Khattab M; Chuncharunee S; Dung PC; Küpesiz A; Shekhawat A; Sonawane Y; Perez LT; Slader C; Taher AT.
Ann Hematol
(Unknown)
Published: 2023
Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patien…
Hailu S; Kinde S; Cross M; Tsegaye A; Kelemu T; Seifu D; Alemayehu D; Tarekegn A; Jabessa G; Abeje D; Abebe M; Sherif A; Tadesse F; Platzbecker U; Howe R; Gebremedhin A.
Ann Hematol
(Unknown)
Published: 2023
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab …
Nowakowski GS; Yoon DH; Mondello P; Joffe E; Peters A; Fleury I; Greil R; Ku M; Marks R; Kim K; Zinzani PL; Trotman J; Sabatelli L; Waltl EE; Winderlich M; Sporchia A; Kurukulasuriya NC; Cordoba R; Hess G; Salles G.
Ann Hematol
(Unknown)
Published: 2023
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world eviden…
Stork M; Spicka I; Radocha J; Minarik J; Jelinek T; Jungova A; Pavlicek P; Pospisilova L; Sedlak F; Straub J; Pika T; Knechtova Z; Fidrichova A; Boichuk I; Sevcikova S; Maisnar V; Hajek R; Pour L.
Ann Hematol
(Unknown)
Published: 2023
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous st…
Martino M; Gori M; Porto G; Pellicano M; Santoro L; Verduci C; Canale FA; Loteta B; Moscato T; Alati C; Ieracitano MC; Cuzzocrea A; Altomonte M; Florenzano MT; Morabito A; Irrera G; Naso V; Pugliese M; Console G; Ferreri A; Imbalzano L; Tripepi G; Pitino A.
Ann Hematol
(Unknown)
Published: 2023
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outsi…
Luciano L; Latagliata R; Gugliotta G; Annunziata M; Tiribelli M; Martino B; Sica A; Esposito MR; Bocchia M; Galimberti S; Sorà F; Albano F; Palmieri R; Pregno P; Dragani M; Iovine M; Sica S; Iurlo A; Castagnetti F; Rosti G; Breccia M.
Ann Hematol
(Unknown)
Published: 2023
G6PD deficiency-does it alter the course of COVID-19 infections?
Ann Hematol
(Unknown)
Published: 2023
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem…
van der Zouwen B; Koster EAS; von dem Borne PA; Oosten LEM; Roza-Scholten MWI; Snijders TJF; van Lammeren D; van Balen P; Marijt WAF; Veelken H; Falkenburg JHF; de Wreede LC; Halkes CJM.
Ann Hematol
(Unknown)
Published: 2023
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis:…
Suzuki K; Wechalekar AD; Kim K; Shimazaki C; Kim JS; Ikezoe T; Min CK; Zhou F; Cai Z; Chen X; Iida S; Katoh N; Fujisaki T; Shin HJ; Tran N; Qin X; Vasey SY; Tromp B; Weiss BM; Comenzo RL; Kastritis E; Lu J.
Ann Hematol
(Unknown)
Published: 2023